To confirm the function of PERK in the regulation of the resistance to BRAFi in BRAFV600E mutant melanoma with impaired PTEN, we examined whether downregulation of PERK in BRAFi-resistant, PTEN-deficient melanoma with elevated PERK could rescue the sensitivity of resistant melanoma to BRAF inhibition. This evidence concerns the gene BRAF and melanoma.